financetom
Business
financetom
/
Business
/
Lilly's oral GLP-1 drug helps reduce blood sugar levels in late-stage trials
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lilly's oral GLP-1 drug helps reduce blood sugar levels in late-stage trials
Oct 15, 2025 4:23 AM

Oct 15 (Reuters) - Eli Lilly ( LLY ) said on Wednesday

its oral drug, orforglipron, helped reduce blood sugar levels in

two late-stage trials.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ShiftPixy's Big AI Move: Supercharges Workforce Management With $150M TurboScale Deal
ShiftPixy's Big AI Move: Supercharges Workforce Management With $150M TurboScale Deal
Oct 17, 2024
ShiftPixy, Inc. ( PIXY ) shares are trading higher on Thursday after the company announced its acquisition of TurboScale. TurboScale is an AI technology company focused on scalable GPU cloud infrastructure and the deployment of AI models. This acquisition will allow ShiftPixy ( PIXY ) to introduce enhanced AI-powered features, such as real-time predictive analytics and machine learning-driven automation, to streamline workforce management. ShiftPixy...
Billing software firm Zuora to go private in $1.7 bln deal with Silver Lake, GIC
Billing software firm Zuora to go private in $1.7 bln deal with Silver Lake, GIC
Oct 17, 2024
Oct 17 (Reuters) - Billing software firm Zuora ( ZUO ) said on Thursday it has entered into a definitive agreement to be acquired by buyout firm Silver Lake and Singaporean wealth fund GIC in a deal valued at $1.7 billion. Shares of Zuora ( ZUO ) rose 4.8% in premarket trading. Silver Lake and GIC will acquire all outstanding...
What's Going On With Lucid Stock Thursday?
What's Going On With Lucid Stock Thursday?
Oct 17, 2024
Lucid Group Inc ( LCID ) shares are trading lower Thursday morning after the company announced the pricing of an offering and corresponding investment from an affiliate of the Public Investment Fund (PIF). What To Know: Lucid shares turned sharply lower in extended trading Wednesday after the company said it commenced a public offering of 262,446,931 shares of its common stock....
Elevance Health Lowers Full-Year Earnings Outlook Following Mixed Third-Quarter Results
Elevance Health Lowers Full-Year Earnings Outlook Following Mixed Third-Quarter Results
Oct 17, 2024
09:02 AM EDT, 10/17/2024 (MT Newswires) -- Elevance Health ( ELV ) slashed its full-year earnings outlook on Thursday as the health insurer's third-quarter revenue beat Wall Street estimates while bottom-line results missed expectations amid challenges in the Medicaid business. The company now anticipates adjusted earnings of about $33 per share for 2024, down from its previous guidance of at...
Copyright 2023-2026 - www.financetom.com All Rights Reserved